Etid klinik pou Dyabèt nan Nevada
3 etid pou Dyabèt ap chèche patisipan nan sit nan Nevada.
Tèks ofisyèl etid la (Anglè)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- DaVita Clinical Research - Henderson, Henderson
- Kidney Specialists of Southern Nevada, Las Vegas
- Sierra Nevada Specialty Care, Reno
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Las Vegas
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284901SPYRAL GEMINI Pilot Study
- Renown Regional Medical Center, Reno
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Jun 24, 2026 · NCT06907147Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.